Total Payments
$1,788
2024 Payments
$174.61
Companies
28
Transactions
117
Medicare Patients
3,217
Medicare Billing
$288,233
Payment Breakdown by Category
Food & Beverage$1,782 (99.7%)
Education$6.00 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,782 | 116 | 99.7% |
| Education | $6.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $198.39 | 11 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $196.01 | 12 | $0 (2022) |
| PFIZER INC. | $190.08 | 13 | $0 (2023) |
| Novo Nordisk Inc | $162.84 | 12 | $0 (2024) |
| ABBVIE INC. | $132.82 | 7 | $0 (2024) |
| Lilly USA, LLC | $121.86 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $98.30 | 8 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $74.05 | 4 | $0 (2020) |
| Merck Sharp & Dohme LLC | $62.44 | 4 | $0 (2023) |
| Amgen Inc. | $59.15 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $174.61 | 9 | ABBVIE INC. ($49.47) |
| 2023 | $223.53 | 13 | AbbVie Inc. ($53.79) |
| 2022 | $106.55 | 7 | ABBVIE INC. ($29.56) |
| 2020 | $108.92 | 7 | PFIZER INC. ($27.46) |
| 2019 | $449.50 | 26 | AstraZeneca Pharmaceuticals LP ($111.96) |
| 2018 | $376.33 | 28 | Novo Nordisk Inc ($67.78) |
| 2017 | $348.18 | 27 | PFIZER INC. ($63.88) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 3 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/17/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Neuroscience | ||||||
| 04/11/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: DIABETES | ||||||
| 04/03/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: UROLOGY | ||||||
| 03/20/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: RESPIRATORY | ||||||
| 03/14/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $6.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/13/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/27/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/20/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $20.57 | General |
| Category: Cardiovascular | ||||||
| 02/13/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Diabetes | ||||||
| 02/06/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/23/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $80.81 | General |
| 01/16/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2018 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Central Nervous System | ||||||
| 12/06/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Obesity | ||||||
| 11/30/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Anemia | ||||||
| 11/14/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: DIABETES | ||||||
| 10/17/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: DIABETES | ||||||
| 10/11/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/03/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Diabetes | ||||||
| 08/29/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Central Nervous System (CNS) | ||||||
| 08/23/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: DIABETES | ||||||
| 08/15/2018 | PFIZER INC. | TOVIAZ (Drug), LYRICA | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 710 | 1,071 | $143,609 | $75,936 |
| 2022 | 10 | 618 | 879 | $100,692 | $54,666 |
| 2021 | 16 | 854 | 1,235 | $147,110 | $79,744 |
| 2020 | 19 | 1,035 | 1,426 | $168,243 | $77,887 |
Total Patients
3,217
Total Services
4,611
Medicare Billing
$288,233
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 157 | 157 | $35,953 | $19,686 | 54.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 212 | $31,376 | $16,414 | 52.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 142 | 280 | $29,680 | $14,438 | 48.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 25 | 25 | $11,120 | $7,048 | 63.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 45 | 45 | $5,526 | $3,411 | 61.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 14 | $5,558 | $2,992 | 53.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 17 | $4,760 | $2,680 | 56.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 18 | 48 | $5,760 | $2,439 | 42.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 20 | 20 | $4,540 | $2,088 | 46.0% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 19 | 63 | $4,914 | $1,588 | 32.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 47 | $1,551 | $1,380 | 89.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 55 | 104 | $1,976 | $990.08 | 50.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 25 | 25 | $825.00 | $734.00 | 89.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 14 | $70.00 | $47.74 | 68.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 128 | 128 | $29,312 | $16,331 | 55.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 156 | $23,088 | $12,911 | 55.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 145 | 238 | $25,228 | $12,900 | 51.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 56 | 56 | $5,600 | $3,934 | 70.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 21 | 41 | $4,920 | $2,037 | 41.4% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 23 | 66 | $5,148 | $2,036 | 39.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 69 | 69 | $2,277 | $1,930 | 84.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 13 | 18 | $2,862 | $1,268 | 44.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 52 | 91 | $1,729 | $870.07 | 50.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 16 | 16 | $528.00 | $448.33 | 84.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 196 | 196 | $44,884 | $25,603 | 57.0% |
About Dr. Jill Badik, DO
Dr. Jill Badik, DO is a Family Medicine healthcare provider based in Fostoria, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1568649069.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jill Badik, DO has received a total of $1,788 in payments from pharmaceutical and medical device companies, with $174.61 received in 2024. These payments were reported across 117 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($1,782).
As a Medicare-enrolled provider, Badik has provided services to 3,217 Medicare beneficiaries, totaling 4,611 services with total Medicare billing of $288,233. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Fostoria, OH
- Active Since 01/28/2008
- Last Updated 05/02/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1568649069
Products in Payments
- JARDIANCE (Drug) $145.56
- VRAYLAR (Drug) $91.66
- CHANTIX (Drug) $80.67
- Ozempic (Drug) $72.73
- FARXIGA (Drug) $67.86
- XIFAXAN (Drug) $56.73
- UBRELVY (Drug) $52.33
- Victoza (Drug) $49.81
- XARELTO (Drug) $45.45
- REXULTI (Drug) $43.14
- JANUVIA (Drug) $41.84
- Saxenda (Drug) $40.30
- Prolia (Biological) $34.62
- ENTRESTO (Drug) $33.67
- MOUNJARO (Drug) $32.77
- TOUJEO (Drug) $31.48
- MYDAYIS (Drug) $30.35
- INVOKANA (Drug) $28.60
- HUMALOG (Drug) $26.76
- PREVNAR 20 (Biological) $25.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fostoria
Dr. Michael Badik, Do, DO
Family Medicine — Payments: $1,128
Family Medicine $1,128
Dr. Samantha Carson, Do, DO
Family Medicine — Payments: $752.42
Family Medicine $752.42
Mr. Tim Beidelschies, Md, MD
Family Medicine — Payments: $92.70
Family Medicine $92.70
Alisa Ingram, Md, MD
Family Medicine
Family Medicine
Dr. Pramuan Thirasilpa, Md, MD
Family Medicine
Family Medicine
Edwin Davis, Md, MD
Family Medicine
Family Medicine